Fifth, significantly lower incidence of proliferative DR and composite surgical outcome were observed in SGLT2i users than GLP1 users in all subgroup analysis, which strengthen the power of evidence in this study
Each patient completed a questionnaire previously utilized by several groups [6, 16, 17], including ours [18], which also let specifically trained nurses know individual injection sites, where skin lesions were then looked for, according to a structured protocol
Glutathione reductase activity is lower in all colorectal carcinoma groups than in control, and a significant decrease in glutathione reductase activity was obtained between patients in tumor stage II and III compared to tumor stage IV
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al